| Jan 16, 2026 |
Jan 20, 2026 |
Matsuda Kazuko
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 16, 2026 |
Jan 20, 2026 |
IWAKI YUICHI
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 17, 2025 |
Jun 20, 2025 |
Nagao Hideki
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 17, 2025 |
Jun 20, 2025 |
Lemerond Nicole
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 17, 2025 |
Jun 20, 2025 |
BEAVER CAROLYN
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 12, 2025 |
Feb 14, 2025 |
Nagao Hideki
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 12, 2025 |
Feb 14, 2025 |
Matsuda Kazuko
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 12, 2025 |
Feb 14, 2025 |
Lemerond Nicole
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 12, 2025 |
Feb 14, 2025 |
IWAKI YUICHI
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 12, 2025 |
Feb 14, 2025 |
BEAVER CAROLYN
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 7, 2025 |
Jan 10, 2025 |
Matsuda Kazuko
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 7, 2025 |
Jan 10, 2025 |
IWAKI YUICHI
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 11, 2024 |
Jun 12, 2024 |
Nagao Hideki
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 11, 2024 |
Jun 12, 2024 |
Lemerond Nicole
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 11, 2024 |
Jun 12, 2024 |
BEAVER CAROLYN
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 9, 2024 |
Jan 11, 2024 |
OBrien Geoffrey
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 9, 2024 |
Jan 11, 2024 |
Matsuda Kazuko
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 9, 2024 |
Jan 11, 2024 |
IWAKI YUICHI
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 4, 2023 |
Aug 8, 2023 |
Lemerond Nicole
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 8, 2023 |
Lemerond Nicole
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 13, 2023 |
Jun 15, 2023 |
Nagao Hideki
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 13, 2023 |
Jun 15, 2023 |
BEAVER CAROLYN
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 23, 2023 |
Jan 25, 2023 |
IWAKI YUICHI
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 23, 2023 |
Jan 25, 2023 |
OBrien Geoffrey
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 23, 2023 |
Jan 25, 2023 |
Matsuda Kazuko
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 28, 2022 |
Nov 30, 2022 |
Nagao Hideki
|
Director |
Sell |
26.3
|
-6,754
|
-100.00%
|
✗
|
$15.2K |
| Nov 21, 2022 |
Nov 23, 2022 |
Nagao Hideki
|
Director |
Sell |
26.3
|
-5,583
|
-45.25%
|
✗
|
$12.2K |
| Nov 17, 2022 |
Nov 21, 2022 |
Nagao Hideki
|
Director |
Sell |
27.5
|
-309
|
-2.44%
|
✗
|
$673.6 |
|
Jun 27, 2022 |
Kruger Jason J
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 16, 2022 |
Jun 17, 2022 |
Nagao Hideki
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 16, 2022 |
Jun 17, 2022 |
BEAVER CAROLYN
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 27, 2022 |
Jan 31, 2022 |
OBrien Geoffrey
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 27, 2022 |
Jan 31, 2022 |
Matsuda Kazuko
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 27, 2022 |
Jan 31, 2022 |
IWAKI YUICHI
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 23, 2021 |
Aug 25, 2021 |
Matsuda Kazuko
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 10, 2021 |
Paulin Douglas
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 9, 2021 |
Jul 23, 2021 |
IWAKI YUICHI
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 24, 2021 |
Jun 28, 2021 |
Matsuda Kazuko
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 16, 2021 |
Jun 21, 2021 |
Nagao Hideki
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 16, 2021 |
Jun 21, 2021 |
BEAVER CAROLYN
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 19, 2021 |
May 20, 2021 |
OBrien Geoffrey
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 22, 2021 |
Apr 26, 2021 |
Gaeta Federico C.A.
|
Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Apr 26, 2021 |
Gaeta Federico C.A.
|
Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 11, 2021 |
Mar 15, 2021 |
Nagao Hideki
|
Director |
Sell |
26.3
|
-2,354
|
-15.69%
|
✗
|
$17.4K |
| Feb 25, 2021 |
Mar 1, 2021 |
IWAKI YUICHI
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 2, 2021 |
Feb 4, 2021 |
OBrien Geoffrey
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 2, 2021 |
Feb 4, 2021 |
Matsuda Kazuko
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 2, 2021 |
Feb 4, 2021 |
IWAKI YUICHI
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 21, 2021 |
3D Investment Partners Pte. Ltd.
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 20, 2020 |
Oct 22, 2020 |
BEAVER CAROLYN
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Oct 22, 2020 |
BEAVER CAROLYN
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 15, 2020 |
Sep 16, 2020 |
Nagao Hideki
|
Director |
Sell |
27.5
|
-1,000
|
-6.25%
|
✗
|
$5.8K |
| Aug 6, 2020 |
Aug 7, 2020 |
Nagao Hideki
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jun 24, 2020 |
Stepanow Edward C Jr.
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 16, 2020 |
Jun 17, 2020 |
Nagao Hideki
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 16, 2020 |
Jun 17, 2020 |
Kobayashi Yutaka
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 12, 2020 |
Jun 15, 2020 |
Matsuda Kazuko
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 8, 2020 |
Apr 13, 2020 |
Matsuda Kazuko
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 8, 2020 |
Apr 13, 2020 |
IWAKI YUICHI
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 13, 2020 |
Mar 16, 2020 |
Matsuda Kazuko
|
Chief Medical Officer |
Buy |
77.5
|
+2,000
|
1.82%
|
✗
|
$7.2K |
| Mar 13, 2020 |
Mar 13, 2020 |
Matsuda Kazuko
|
Chief Medical Officer |
Buy |
77.5
|
+2,000
|
1.83%
|
✗
|
$7.2K |
| Mar 12, 2020 |
Mar 12, 2020 |
IWAKI YUICHI
|
CEO |
Buy |
82.5
|
+20,000
|
2.26%
|
✗
|
$62K |
| Jan 9, 2020 |
Jan 10, 2020 |
OBrien Geoffrey
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 9, 2020 |
Jan 10, 2020 |
Matsuda Kazuko
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 9, 2020 |
Jan 10, 2020 |
IWAKI YUICHI
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 12, 2019 |
Jun 13, 2019 |
Matsuda Kazuko
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 10, 2019 |
Jun 11, 2019 |
Nagao Hideki
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 10, 2019 |
Jun 11, 2019 |
Kobayashi Yutaka
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 10, 2019 |
Jun 11, 2019 |
Ishizaka Yoshio
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 13, 2019 |
May 14, 2019 |
Nagao Hideki
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 28, 2019 |
Mar 4, 2019 |
Okajima Masatsune
|
VP and Head of Japanese Office |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 15, 2019 |
Jan 17, 2019 |
Okajima Masatsune
|
VP and Head of Japanese Office |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 15, 2019 |
Jan 17, 2019 |
OBrien Geoffrey
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 15, 2019 |
Jan 17, 2019 |
Matsuda Kazuko
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 15, 2019 |
Jan 17, 2019 |
IWAKI YUICHI
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 9, 2019 |
Jan 11, 2019 |
Okajima Masatsune
|
VP and Head of Japanese Office |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 3, 2019 |
Jan 7, 2019 |
IWAKI YUICHI
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 7, 2018 |
Jun 8, 2018 |
Nagao Hideki
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 7, 2018 |
Jun 8, 2018 |
Kobayashi Yutaka
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 7, 2018 |
Jun 8, 2018 |
Ishizaka Yoshio
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jun 5, 2018 |
Reyes Carla
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 5, 2018 |
Mar 7, 2018 |
IWAKI YUICHI
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 6, 2018 |
Jan 9, 2018 |
Okajima Masatsune
|
VP and Head of Japanese Office |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 6, 2018 |
Jan 9, 2018 |
OBrien Geoffrey
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 6, 2018 |
Jan 9, 2018 |
Matsuda Kazuko
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 6, 2018 |
Jan 9, 2018 |
IWAKI YUICHI
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 3, 2018 |
Jan 5, 2018 |
IWAKI YUICHI
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 12, 2017 |
Dec 14, 2017 |
Okajima Masatsune
|
VP and Head of Japanese Office |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 9, 2017 |
Nov 13, 2017 |
Nagao Hideki
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Nov 13, 2017 |
Nagao Hideki
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 2, 2017 |
Nov 6, 2017 |
IWAKI YUICHI
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 21, 2017 |
Aug 23, 2017 |
Ishizaka Yoshio
|
Director |
Buy |
91.3
|
+5,000
|
50.00%
|
✗
|
$25.9K |
| Jun 8, 2017 |
Jun 9, 2017 |
Kobayashi Yutaka
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 8, 2017 |
Jun 9, 2017 |
Ishizaka Yoshio
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 15, 2017 |
May 16, 2017 |
Kobayashi Yutaka
|
Director |
Buy |
67.5
|
+1,000
|
0.95%
|
✗
|
$5.6K |
| May 12, 2017 |
May 15, 2017 |
Kobayashi Yutaka
|
Director |
Buy |
95.0
|
+24,000
|
29.34%
|
✗
|
$134.9K |
| Jan 18, 2017 |
Jan 20, 2017 |
Okajima Masatsune
|
VP and Head of Japanese Office |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 18, 2017 |
Jan 20, 2017 |
OBrien Geoffrey
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 18, 2017 |
Jan 20, 2017 |
Matsuda Kazuko
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 18, 2017 |
Jan 20, 2017 |
IWAKI YUICHI
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |